Vasc Q Laminate Med

Vasq laminate medical technologies israel is an external support device for avfs designed to improve flow and reduce neointimal hyperplasia at the anastomotic site.

Vasc q laminate med.

Laminate medical technologies said today it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular. Vasq is the only solution currently available2that addresses both hemodynamic and mechanical stress to create more usable fistulas promote outward dilative remodeling the nitinol external support controls the remodeling at the anastomosis to promote outward wall thickening downstream for eventual use in hemodialysis. Preliminary data are presented of its use assessing its safety and efficacy for brachiocephalic avfs in haemodialysis patients. 23 2019 prnewswire the israeli start up laminate medical technologies developer of the vasq external vascular support device for arteriovenous fistulas in patients.

Tel aviv israel oct. Eyal orion who began their work in the rad biomed incubator. Laminate medical technologies was founded in 2012 by tammy gilon and dr. On january 19th laminate medical technologies announced that it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis.

A post market surveillance study to assess the safety and effectiveness of vasq value the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Laminate has developed vasq a blood vessel support device for.